Breast cancer has been on the rise of becoming one of the number one death factors for women. Breast cancer has proved to be one of the deadliest diseases for women. At the earliest stage, women have a 7% chance of dying from breast cancer.
I recently examined New York Times article, ¨Immune-Based Treatment Helps Fight Aggressive Breast Cancer, Study Finds,¨ by Denise Grady which was about a major study proving that women with an aggressive type of breast cancer lived longer if they received immunotherapy plus chemotherapy, rather than chemo alone.

This graph demonstrates how the mortality rate for women has slowly gone down with new treatments developed.
The article emphasized how similar the number of deaths was to the number of women diagnosed with a more aggressive type of breast cancer. Chemotherapy has been a treatment used for all cancers but even it cannot treat a more invasive type. A combination of immunotherapy and chemotherapy has been proven to shrink tumors in the body and removing all signs of cancer.
I have lost many people in my life to breast cancer and so this breakthrough for potential survival is groundbreaking. The people who I have known that were diagnosed fought until their last day. Breast cancer was just too strong. They went through many therapies which would only cause them pain but they continued on with their fight.
Grady acknowledges that many deaths have been caused by the invasive type of breast cancer. According to Grady, “Although triple-negative tumors occur in only about 15 percent of patients with invasive breast cancer in the United States (or nearly 40,000 each year), they account for a disproportionate share of deaths, as many as 30 percent to 40 percent.” Grady’s point is that we have been needing to find some sort of therapy to treat this invasive type and groundbreaking news has proved that we have.
I agree that a combined treatment of immunotherapy and chemotherapy will be beneficial to many families and fighters because my experience with someone who had an invasive type confirms it. We lost her to Stage 4 breast cancer because the treatment was not strong enough.
Although I grant that this invasive treatment may be more harmful and intense to the patient receiving it, I still maintain that in the end, it will be beneficial. Ultimately, what is at stake here is being able to find a cure for all types of cancers and we can do that by targeting one at a time.




